• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. TWINFIX TI 2.8 ULTRABRAID; STAPLE, FIXATION, BONE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. TWINFIX TI 2.8 ULTRABRAID; STAPLE, FIXATION, BONE Back to Search Results
Model Number 72200750
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hypersensitivity/Allergic reaction (1907)
Event Date 10/22/2021
Event Type  Injury  
Event Description
It was reported that on (b)(6) 2021, a right shoulder joint arthroscopy and bankart repair were performed to treat the patient's recurrent right shoulder dislocations.A total of three titanium (3) twinfix ultrabraid suture anchors were used.The patient was discharged on (b)(6) 2021, but one month after surgery, itchy hives started to appear throughout the patient's body, and spread to the limbs, with itching and swelling of the lips.The patient self-kept to a hypoallergenic diet without any effect.The patient took ag (zyrtec, cetirizine) once every 2 days with moderate effect, and linear urticaria (dermographism) began to appear.The patient was diagnosed with chronic spontaneous urticaria (titanium fasteners) and recurrent angioedema.It is unknown what remedial actions were taken and the current health status of the patient is unknown.
 
Manufacturer Narrative
H10: internal complaint reference (b)(4).
 
Manufacturer Narrative
H3, h6: a device deficiency was not identified, and the root cause of the reported event could not be determined since the device was not returned for evaluation.A review of device records showed there were no indications to suggest that the product did not meet manufacturing specifications upon release for distribution.A complaint history review found no similar reported events.The instructions for use were reviewed and found to include conditions of off label use and technique specifics, as well as precautions and warnings related to the use of the device.A risk management review found that the reported failure and/or harm was documented appropriately, and there were no indications to suggest the anticipated risk is not adequate.A clinical review states the source of the itchy hives reported to appear throughout his body, spreading to the limbs, the 5¿6-point pruritus and the swelling of the lips cannot be confirmed, but allergy cannot be ruled out.It is unknown if an underlying medical condition, not seeking early medical intervention could have contributed to the unresolved symptoms.However, it was reported the patient has been advised to follow up with an allergist.Please refer to the instructions for use for recommendations on proper use of the device and potential troubleshooting methods to prevent future reoccurrence of the reported event.No containment or corrective actions are recommended at this time.If the product associated with this event is returned at a future date, this investigation will be reopened for evaluation.Corrected data: h6: health effect - impact code.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TWINFIX TI 2.8 ULTRABRAID
Type of Device
STAPLE, FIXATION, BONE
Manufacturer (Section D)
SMITH & NEPHEW, INC.
130 forbes blvd.
mansfield MA 02048
Manufacturer (Section G)
SMITH & NEPHEW, INC.
130 forbes blvd.
mansfield MA 02048
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key16864593
MDR Text Key314505439
Report Number1219602-2023-00645
Device Sequence Number1
Product Code JDR
UDI-Device Identifier03596010584472
UDI-Public03596010584472
Combination Product (y/n)N
Reporter Country CodeRS
PMA/PMN Number
K972326
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/03/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number72200750
Device Catalogue Number72200750
Device Lot Number2048129
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/17/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/19/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
FLUXUM, RIVAROXABAN AND CEFAZOLIN.
Patient Outcome(s) Hospitalization; Other;
Patient Age32 YR
Patient SexMale
-
-